3D LifePrints rebrands as Insight Surgery and achieves second FDA clearance

UK-based medical 3D printing specialist 3D LifePrints announced its rebranding as Insight Surgery, at the official launch of its US business in Houston.

The rebranding coincides with the company receiving its second FDA 510(k) clearance for non-joint replacing osteotomies in the appendicular skeleton including bone tumor resection. 3D LifePrints claims, it is thought to be the widest clearance obtained thus far, encompassing both the upper and lower extremities. In addition, Insight Surgery revealed the opening of its cleanroom production facility at the Texas Medical Center. According to 3D LifePrints, the rebranding represents the organization’s progression from a UK-based medical 3D printing business to a cross-Atlantic provider of Personalized Surgery.

Paul Fotheringham, Insight Surgery CTO said, “Our 2 recent FDA clearances enable us to bring our full range of CMF and Orthopaedic devices to the US market. Our aim is to put these highly impactful devices in surgeons’ hands within 5 days of receipt of scan data.”

3D LifePrints to Insight Surgery – a sophisticated journey

The official USA launch of Insight Surgery took place at the residence of the British Consulate General in Houston. It was attended by many members of Houston’s medical and academic communities, along with representatives from Houston Methodist, Texas Children’s Hospital, MD Anderson, and Texas Medical Center Innovations.

 “I’m delighted to be back again amongst so many friends and colleagues in Houston. Texas quickly became our first choice as a landing spot and given its proximity to so many world-class hospitals, the Texas Medical Center is an ideal location for our first US facility,” added Peter Ellingworth, Chairman of Insight Surgery.

The FDA-cleared digital platform EmbedMed from Insight Surgery is an end-to-end solution for surgeons that digitizes the surgical planning procedure and allows for the quick design and manufacture of patient-specific medical devices. Embedmed’s capabilities entail patient scan data processing and serving as a pre-operative software tool for simulating and assessing surgical planning options. The system’s output files can be delivered in digital format or as surgical guides and physical models to be employed during surgery.

“Firstly, I’d like to thank Houston for such a warm welcome. We have chosen the launch of our US business as the ideal time to rename the company to “Insight Surgery” so that it aligns with our focus on Digital Planning and Personalized Surgery. Having supplied Personalized Devices to over 1000 surgeries in the UK we now turn our attention to the US market, specifically Texas,” said Henry Pinchbeck, Co-Founder, and Chief Executive Officer.